Mpox Vaccines and EU's Commitment to Africa CDC
Wednesday, 14 August 2024, 09:00
Mpox Vaccines: EU's Initiative for Africa
The EU is taking critical steps to combat health challenges by securing 215,000 Mpox vaccines for the Africa CDC. The MVA-BN® vaccine is designed to strengthen health responses across the continent. Here are key points about this initiative:
- 215,000 vaccines from EU procured for Africa CDC
- Health Emergency Preparedness and Response Authority (HERA) oversees the procurement
- The move aims to bolster Africa's health defenses against Mpox
Significance of the Vaccination Effort
This vital initiative showcases Europe's commitment to global health and addresses pressing health emergencies directly.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.